GSK-109216

Study Sponsor: GSK

Study Title

Immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) liquid vaccine (GSK 357941A) in healthy infants.

Medicine or Vaccine (generic name)

Rotavirus Vaccine

Sponsor Identification Number

109216

Trial Registry Identification Number(#'s)

NCT00432380 2015-001544-11

Medical Condition

Infections, Rotavirus

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=109216

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00432380

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2015-001544-11

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2013